Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.98, demonstrating a +1.32% change from the preceding day's closing price. The stock's change was more than the S&P 500's daily ...

Researchers who track the elusive and reviled reptiles were thrilled to witness one of the greedy beasts regurgitating an ...

Let’s first get this out of the way: generational stereotypes don’t stand up well to scrutiny. The psychological evidence is clear. The variation within generations far outweighs any average ...

One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. The company was the target of an analyst price ...

It’s not unusual for comedians to have sticking points when it comes to perceived boundaries on their expression, but their commitment to preserving the R-word specifically speaks to either a ...

Timing is everything in politics and the law, and Los Angeles County District Attorney Nathan Hochman certainly is using it to his presumed advantage today when it comes to the Menendez brothers and ...

A recent ruling from Germany’s Federal Supreme Court (BGH) has revived a legal battle over whether browser-based ad blockers infringe copyright, raising fears about a potential ban of the tools in the ...

August 13 - If we want the global economy to stay stable, competitive and sustainable, we need to urgently rethink how we manage the world’s natural resources. In the last decades we have built highly ...

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7) SALT LAKE CITY, Aug. 05, 2025 ...